Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q1 2023
- Shares held
- 399.4K
- +40.4K (+11.2%) vs. Q1 2023
- Total value
- $1.63M
- +$523.7K (+47.4%) vs. Q1 2023
- New holders
- 1
- 7 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DSC Advisors, L.P. | 115,000 | $466.9K | 0.73% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 76,380 | $310.1K | 0.00% | +58,368+324.1% | Added |
| BlackRock Inc. | 49,110 | $201.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 44,896 | $184.1K | 0.00% | +7,038+18.6% | Added |
| Renaissance Technologies LLC | 36,076 | $148.0K | 0.00% | +10,495+41.0% | Added |
| Geode Capital Management, LLC | 24,945 | $101.3K | 0.00% | 00.0% | Unchanged |
| Staley Capital Advisers Inc | 23,472 | $96.2K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 11,665 | $47.4K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 7,520 | $30.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,200 | $17.2K | 0.00% | −550−11.6% | Reduced |
| Morgan Stanley | 2,210 | $9.06K | 0.00% | +885+66.8% | Added |
| Royal Bank of Canada | 1,407 | $6.00K | 0.00% | +1,195+563.7% | Added |
| UBS Group AG | 1,086 | $4.45K | 0.00% | +721+197.5% | Added |
| MB, Levis & Associates, LLC | 1,041 | $4.27K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 187 | $759 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 127 | $521 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 89 | $365 | 0.00% | +2+2.3% | Added |
| Steward Partners Investment Advisory, LLC | 22 | $90 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 8 | $32 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6 | $24 | 0.00% | +6 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −27,312−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,304−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −115−100.0% | Sold out |